- In anticipation of bleeding, drugs that diminish bleeding can be given to patients.
- In long term transfusion dependent patients, for example dialysis patients, red cell stimulating drugs like erythropoetin can be give.
- Recombinant technology allows the production of virus free proteins. This technology is currently in use for the production of coagulation factors.